+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Growth Opportunities in Digital Therapeutics, Exascale Computing, and Wastewater Treatment

  • ID: 5406483
  • Report
  • July 2021
  • Region: Global
  • 28 Pages
  • Frost & Sullivan

This edition of the Inside R&D Technology Opportunity Engine (TOE) covers innovations related to digital therapeutics, personalized and precise treatment for chronic diseases, and exascale computing technology to enhance the performance efficiency of small and modular nuclear reactors. The TOE highlights recent innovative solutions providing effective type-2 diabetes management in real time. The TOE also features the use of avocado seeds for the manufacture of bioplastics, and the deployment of biological phosphorous removal systems that enhance water treatment while simultaneously providing nutrients for aquaponics- and hydroponics-based farming systems. The IRD TOE also provides intelligence and insights on innovations spanning a wide variety of industry areas, including electronics, sensors, information and communication technologies, medical devices, materials, coatings, renewable fuels, and innovations that contribute to a cleaner and greener environment.

Inside R&D Technology Opportunity Engine covers global innovations in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment.

Note: Product cover images may vary from those shown

Growth Opportunities in Digital Therapeutics, Exascale Computing, and Wastewater Treatment

  • Innovations in Digital Therapeutics, Exascale Computing, and Wastewater Treatment
    • Genetics and Gut-Microbiome-Based Precise Digital Therapeutics
    • Precision Care Platform for Obesity and Its Associated Digestive, Skin and Cardio-Metabolic Comorbidities
    • Digbi Health - Investor Dashboard
    • Clinically Validated Digital Therapy Platform for Chronic Condition Management
    • Personalized, and Flexible Digital Care Platform
    • Wellthy Therapeutics - Investor Dashboard
    • Exascale Modeling to Improve Nuclear Reactor Design
    • Argonne National Laboratory's Value Proposition Can Improve Smr Design
    • Argonne National Laboratory - Investor Dashboard
    • Sycl Compler to Support Exascale Computing
    • Codeplay Software's Value Proposition Works With Different Architectures Using Familiar Tools
    • Codeplay Software Ltd. - Investor Dashboard
    • Next-Generation Network to Support Exascale Computing
    • Atos Se’s Value Proposition Improves High Performance Computing
    • Atos Se - Investor Dashboard
    • Better Therapeutics LLC, US
    • Biofase, Mexico
    • University of Montreal, Canada
    • University of Gothenburg, Sweden
    • Carbonfree, US
    • Key Contacts
    • Legal Disclaimer
Note: Product cover images may vary from those shown
Adroll
adroll